Aspergillus fumigatus osteomyelitis in a patient receiving alemtuzumab for B-cell chronic lymphocytic leukaemia

Br J Haematol. 2011 Apr;153(2):147. doi: 10.1111/j.1365-2141.2011.08570.x. Epub 2011 Feb 20.

Authors

Sumit Karia¹, Kanagaratnam Jeyapalan, Ben Kennedy

Affiliation

¹ Departments of Haematology Radiology, University Hospitals Leicester, Leicester Royal Infirmary, Leicester, UK. sumitkaria@yahoo.co.uk

PMID: 21332707
DOI: 10.1111/j.1365-2141.2011.08570.x

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Alemtuzumab
Antibodies, Monoclonal, Humanized / administration & dosage
Antibodies, Monoclonal, Humanized / adverse effects*
Antineoplastic Agents / administration & dosage
Antineoplastic Agents / adverse effects*
Aspergillosis* / chemically induced
Aspergillosis* / pathology
Aspergillus fumigatus*
Female
Humans
Leukemia, Lymphocytic, Chronic, B-Cell* / drug therapy
Leukemia, Lymphocytic, Chronic, B-Cell* / pathology
Osteomyelitis* / chemically induced
Osteomyelitis* / pathology

Substances

Antibodies, Monoclonal, Humanized
Antineoplastic Agents
Alemtuzumab